1887

Abstract

Creutzfeldt-Jakob disease (CJD) is one of the transmissible spongiform encephalopathies (TSEs). In all TSEs host susceptibility is an important factor in the development of clinical disease. The prion protein (PrP) gene appears to confer the main component of this susceptibility. The appearance of spontaneous neurodegeneration in PrP transgenic mice carrying a human mutation has raised the possibility that the origin of sporadic CJD is solely genetic. We studied PrP codon 129 polymorphism in 23 of the 25 CJD cases in France related to human growth hormone (hGH) therapy. They constitute the largest and most homogeneous hGH- related iatrogenic CJD population yet analysed. All these CJD cases were homozygous at codon 129, compared with only 50% in the healthy control group ( 0·00002). These iatrogenic cases also displayed a genotype frequency distribution similar to that observed in sporadic CJD. These results underline the importance of the PrP gene and especially the homozygous codon 129 genotype in determining the risk of developing CJD after contamination by a TSE agent. They also suggest that highly susceptible individuals may exist and raise the possibility that sporadic CJD may have an environmental origin.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-1-23
1994-01-01
2023-02-02
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/1/JV0750010023.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-1-23&mimeType=html&fmt=ahah

References

  1. Billette De Villemeur T., Gourmelen M., Beauvais P., Rodriguez D., Vaudour G., Deslys J. P., Dormont D., Richard P., Richardet J. M. 1992; Creutzfeldt-Jakob disease in four children treated with growth hormone. Revue Neurologique (Paris) 148:328–334
    [Google Scholar]
  2. Brown P. 1992; The phenotype expression of different mutations in transmissible human spongiform encephalopathy. Revue Neurologique (Paris) 148:317–327
    [Google Scholar]
  3. Chesebro B. 1992; PrP and the scrapie agent. Nature; London: 356560
    [Google Scholar]
  4. Clément J. M., Lalande F., Reyrole L., Viossat L. C. 1992; Rapport sur l’hormone de croissance et la maladie de Creutzfeldt- Jakob. Inspection Generate des Affaires Sociales, IGAS/SA 19/n° 92145
    [Google Scholar]
  5. Collinge J., Palmer M. S., Dryden A. J. 1991; Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337:1441–1442
    [Google Scholar]
  6. Diringer H., Gelderblom H., Hilmert H., Ozel M., Edelbluth C., Kimberlin R. H. 1983; Scrapie infectivity. fibrils and low molecular weight protein. Nature; London: 306476–478
    [Google Scholar]
  7. Doh-Ura K., Kitamoto T., Sasaki H., Tateishi J. 1991; CJD discrepancy. Nature; London: 353801–802
    [Google Scholar]
  8. Doh-Ura K., Tateishi J., Sasaki H., Kitamoto T., Sakaki Y. 1989; Pro-Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome. Biochemical and Biophysical Research Communications 163:974–979
    [Google Scholar]
  9. Goldfarb L. G., Brown P., Goldgaber D., Asher D. M., Granpera G., Piccardo P., Brown W. T., Rubenstein R., Boellaard J. W., Gajdusek D. C. 1989; Patients with Creutzfeldt-Jakob disease and Kura lack the mutation in the PRIP gene found in Gerstmann-Straussler syndrome, but they show a different double allele mutation in the same gene. American Journal of Human Genetics 45:A189
    [Google Scholar]
  10. Goldfarb L. G., Haltia M., Brown P., Nieto A., Kovanen J., Mccombie W. R., Trapp S., Gajdusek D. C. 1991; New mutation in scrapie amyloid precursor gene in Finnish Creutzfeldt- Jakob disease kindred. Lancet 337:425
    [Google Scholar]
  11. Goldgaber D., Goldfarb L. G., Brown P., Asher D. M., Brown W. T., Lin S., Teener J. W., Feinstone S. M., Rubenstein R., Kascsak R. J., Boellaard J. W., Gajdusek D. C. 1989; Mutation in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker syndrome. Experimental Neurologv 106:204–206
    [Google Scholar]
  12. Hope J., Morton L. J. D., Farquhar C. F., Muilthaup G., Beyreuther K., Kimberlin R. H. 1986; The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein. EMBO Journal 5:2591–2597
    [Google Scholar]
  13. Hsiao K. K., Baker H. F., Crow T. J., Poulter M., Owen F., Terwilliger J. D., Westaway D., Ott J., Prusiner S. B. 1989; Linkage of a prion protein missense variant to Gerstmann- Straussler syndrome. Nature; London: 338342–345
    [Google Scholar]
  14. Hsiao K. K., Scott M., Foster D., Groth D. F., Dearmond S. J., Prusiner S. B. 1990; Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590
    [Google Scholar]
  15. Hsiao K. K., Dlouhy S. R., Farlow M. R., Cass C., Dacosta M., Conneally P. M., Hodes M. E., Ghetti B., Prusiner S. B. 1992; Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nature Genetics 1:68–71
    [Google Scholar]
  16. Job J. C., Maillard F., Goujard J. 1992; Epidemiologic survey of patients treated with growth hormone in France in the period 1959–1990-preliminary results. Hormone Research 38:35–43
    [Google Scholar]
  17. Kascsak R. J., Rubenstein R., Merz P. A., Carp R. I., Wisniewski H. M., Diringer H. 1985; Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. Journal of General Virology 66:1715–1722
    [Google Scholar]
  18. Owen F., Poulter M., Collinge J., Crow T. J. 1990; Codon 129 changes in the prion protein gene in Caucasians. American Journal of Human Genetics 461215–1216
    [Google Scholar]
  19. Palmer M. S., Dryden A. J., Hughes J. T., Collinge J. 1991; Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature; London: 352340–342
    [Google Scholar]
  20. Prusiner S. B. 1991; Novel properties and biology of scrapie prions. In Transmissible Spongioform Encephalopathies: Scrapie, BSE and Related Diseases pp 233–257 Chesebro B. W. Edited by Berlin & Heidelberg: Springer-Verlag;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-1-23
Loading
/content/journal/jgv/10.1099/0022-1317-75-1-23
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error